Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von CandyButcher 

Thermo Fisher Scientific Inc. diskutieren

Thermo Fisher Scientific Inc.

WKN: 857209 / Symbol: TMO / Name: Thermo Fisher / Aktie / Ausrüstung & Versorgung / Large Cap /

493,00 €
0,29 %

Einschätzung Buy
Rendite (%) 20,39 %
Kursziel 470,14
Veränderung
Endet am 11.09.26

Thermo Fisher Scientific (NYSE:TMO) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating. They now have a $550.00 price target on the stock, up previously from $490.00.
Ratings data for TMO provided by MarketBeat

Thermo Fisher Scientific (NYSE:TMO) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Ratings data for TMO provided by MarketBeat

Einschätzung Buy
Rendite (%) 6,49 %
Kursziel 504,33
Veränderung
Endet am 07.10.26

Thermo Fisher Scientific (NYSE:TMO) had its price target raised by analysts at Evercore ISI from $525.00 to $590.00. They now have an "outperform" rating on the stock.
Ratings data for TMO provided by MarketBeat

Einschätzung Buy
Rendite (%) 7,41 %
Kursziel 558,42
Veränderung
Endet am 09.10.26

Thermo Fisher Scientific (NYSE:TMO) had its price target raised by analysts at JPMorgan Chase & Co. from $600.00 to $650.00. They now have an "overweight" rating on the stock.
Ratings data for TMO provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,62 %
Kursziel 499,79
Veränderung
Endet am 22.10.26

Thermo Fisher Scientific (NYSE:TMO) had its price target raised by analysts at Leerink Partners from $545.00 to $580.00. They now have an "outperform" rating on the stock.
Ratings data for TMO provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,43 %
Kursziel 538,69
Veränderung
Endet am 23.10.26

Thermo Fisher Scientific (NYSE:TMO) had its price target raised by analysts at Barclays PLC from $585.00 to $625.00. They now have an "overweight" rating on the stock.
Ratings data for TMO provided by MarketBeat

Thermo Fisher Scientific (NYSE:TMO) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Ratings data for TMO provided by MarketBeat

Einschätzung Buy
Rendite (%) -0,16 %
Kursziel 547,31
Veränderung
Endet am 23.10.26

Thermo Fisher Scientific (NYSE:TMO) had its price target raised by analysts at Wells Fargo & Company from $565.00 to $635.00. They now have an "overweight" rating on the stock.
Ratings data for TMO provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,84 %
Kursziel 563,68
Veränderung
Endet am 23.10.26

Thermo Fisher Scientific (NYSE:TMO) had its price target raised by analysts at TD Cowen from $612.00 to $654.00. They now have a "buy" rating on the stock.
Ratings data for TMO provided by MarketBeat

Thermo Fisher Scientific (NYSE:TMO) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Ratings data for TMO provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,55 %
Kursziel 562,72
Veränderung
Endet am 28.10.26

Thermo Fisher Scientific (NYSE:TMO) was given a new $656.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
Ratings data for TMO provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,49 %
Kursziel 523,69
Veränderung
Endet am 29.10.26

Thermo Fisher Scientific (NYSE:TMO) was given a new $610.00 price target on by analysts at Argus. They now have a "buy" rating on the stock.
Ratings data for TMO provided by MarketBeat

Einschätzung Buy
Rendite (%) -1,73 %
Kursziel 577,14
Veränderung
Endet am 02.12.26

Thermo Fisher Scientific (NYSE:TMO) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $670.00 price target on the stock.
Ratings data for TMO provided by MarketBeat

Thermo Fisher Scientific (NYSE:TMO) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.
Ratings data for TMO provided by MarketBeat